Histone Deacetylase Inhibition Attenuates Aortic Remodeling in Rats under Pressure Overload.
The use of histone deacetylase (HDAC) inhibitor is a novel therapeutic strategy for cardiovascular disease. Studies have shown that many HDAC inhibitors have the ability to reduce the aortic remodeling in various animal models. We hypothesized that the HDAC inhibitor, MGCD0103 (MGCD), attenuates aor...
| Publicado en: | BioMed Research International pp. 1 - 9 |
|---|---|
| Autores principales: | , , , |
| Formato: | pictorial research tables/charts Journal Article |
| Publicado: |
Wiley-Blackwell
7/25/2020
|
| Acceso en línea: | Ver este registro en EBSCOhost |